Klinikum der Universität München

Patient-oriented Comparison of Systemic Therapies for Patients with advanced Melanoma - A multicenter Cross-sectional Study (2021) Thiem A, Mashhadiakbar P, Hassel JC, Grimmelmann I, Gutzmer R, Schlaak M, Heppt M, et al. Conference contribution Pädiatrische epileptische Enzephalopathien mit Manifestation oberhalb des Neugeborenenalters: ein Up-date (2021) Trollmann R, Borggräfe I, Müller-Felber W, Brandl U Journal article, Review article KEYNOTE-522: Phase III study of neoadjuvant pembrolizumab D chemotherapy vs. placebo D chemotherapy, followed by adjuvant pembrolizumab vs. placebo for earlystage TNBC (2021) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur H, Kummel S, Bergh J, et al. Conference contribution A benchmark for neural network robustness in skin cancer classification (2021) Maron RC, Schlager JG, Haggenmüller S, von Kalle C, Utikal JS, Meier F, Gellrich FF, et al. Journal article Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status (2021) Hein A, Hartkopf AD, Emons J, Lux MP, Volz B, Taran FA, Overkamp F, et al. Journal article NNT mediates redox-dependent pigmentation via a UVB- and MITF-independent mechanism (2021) Allouche J, Rachmin I, Adhikari K, Pardo LM, Lee JH, McConnell AM, Kato S, et al. Journal article Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial (2021) Bauer A, Schreinlechner M, Sappler N, Dolejsi T, Tilg H, Aulinger BA, Weiss G, et al. Journal article Expression of surface-associated 82 kda prommp-9 in lymphatic leukemia blast cells differentially correlates with prognosis (2021) Schmohl J, Möbius S, Günther T, Pepeldjyika E, Seidel CL, Sutanto W, Schuster F, et al. Journal article Response to letter entitled: ‘Re: Hematological immune related adverse events after treatment with immune checkpoint inhibitors’ (2021) Heinzerling L, La Rosée P, Gutzmer R, Kramer R, Keller-Stanislawski B, Zierold S, Mentzer D Journal article High rates of therapeutic changes in patients with psoriatic arthritis receiving treatment with disease-modifying antirheumatic drugs: A cross-sectional study (2021) Behrens F, Rech J, Thaci D, Zinke S, Rothnie KJ, (Oefner) Daamen C, Leipe J Journal article